机构：[1]Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China[2]Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention, and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China[3]Brain Tumor Center and Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA[4]CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China[5]Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China外科系统神经外科江苏省人民医院[6]Department of Bioinformatics & Computational Biology, Proteomics and Metabolomics Core Facility, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA[7]School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China[8]MOEKey Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China[9]Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China[10]Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, China研究所北京市神经外科研究所首都医科大学附属天坛医院[11]The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan 450052, China[12]Department of Pathology, University of Iowa, Iowa City, IA 52242, USA[13]Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310029, China科技平台肝胆胰肿瘤精准诊治研究重点实验室浙江大学医学院附属第一医院
第一作者机构：[1]Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China[2]Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention, and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China[3]Brain Tumor Center and Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
共同第一作者：
通讯作者：
通讯机构：[1]Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China[2]Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention, and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China[3]Brain Tumor Center and Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA[13]Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310029, China
推荐引用方式(GB/T 7714)：
Xu Qian ,Xinjian Li ,Zhumei Shi ,et al.PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.[J].Molecular cell.2019,doi:10.1016/j.molcel.2019.08.006.
APA：
Xu Qian,,Xinjian Li,,Zhumei Shi,,Yan Xia,,Qingsong Cai,...&Zhimin Lu.(2019).PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1..Molecular cell,,
MLA：
Xu Qian,,et al."PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.".Molecular cell .(2019)
生物